LongevityBank focuses on autologous therapies, which employ a person's own blood, cells, and tissues.
LongevityBank has raised $500K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
LongevityBank's investors include ICH Group.
LongevityBank is headquartered in Singapore, Singapore.
LongevityBank focuses on autologous therapies, which employ a person's own blood, cells, and tissues.
LongevityBank is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LongevityBank — Funding & Investors." VCBacked, November 6, 2025, https://www.vcbacked.co/company/longevitybank. Accessed July 21, 2026.
VCBacked. (2025). LongevityBank — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/longevitybank
{{cite web |title=LongevityBank — Funding & Investors |url=https://www.vcbacked.co/company/longevitybank |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated